Jadenu 360 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5QT1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,871
Award facts
- Contract value 100% obligated
- $61,871.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $61,871.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 30 tablets of Jadenu 360 mg on January 9, 2026, with an ultimate completion date of January 12, 2026. The contract, which was competitively awarded with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jadenu is a chelation therapy medication used to treat iron overload conditions, reflecting the Defense Logistics Agency's ongoing need to supply specialized pharmaceutical products to military healthcare systems.
This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs and serves as the primary mechanism for delivering a wide range of pharmaceutical products, medical supplies, brand-name and generic drugs, vaccines, and specialized medical commodities to support military treatment facilities and veteran healthcare programs worldwide. The non-set-aside status of this delivery order demonstrates AmerisourceBergen's competitive position as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F5QT1?
SPE2DR26F5QT1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F5QT1 worth?
The government has obligated $61,871 on SPE2DR26F5QT1.
Is contract SPE2DR26F5QT1 an order under another contract?
Yes. SPE2DR26F5QT1 is a delivery order under SPE2DR25D3003, an indefinite delivery contract.
Was contract SPE2DR26F5QT1 competed?
The extent of competition for SPE2DR26F5QT1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award